MENDITTO, ENRICA
 Distribuzione geografica
Continente #
AS - Asia 7.445
NA - Nord America 6.709
EU - Europa 5.418
SA - Sud America 913
AF - Africa 230
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.732
Nazione #
US - Stati Uniti d'America 6.411
SG - Singapore 3.393
RU - Federazione Russa 2.503
VN - Vietnam 1.396
CN - Cina 1.299
IT - Italia 946
BR - Brasile 721
HK - Hong Kong 573
DE - Germania 366
NL - Olanda 354
FR - Francia 298
FI - Finlandia 274
CA - Canada 170
GB - Regno Unito 154
JP - Giappone 153
BD - Bangladesh 120
IN - India 109
IE - Irlanda 105
SE - Svezia 99
AR - Argentina 72
MX - Messico 66
UA - Ucraina 66
CI - Costa d'Avorio 65
ES - Italia 56
ZA - Sudafrica 49
KR - Corea 47
PL - Polonia 46
IQ - Iraq 43
PH - Filippine 43
AT - Austria 37
TH - Thailandia 35
ID - Indonesia 33
EC - Ecuador 32
PK - Pakistan 30
TR - Turchia 29
CO - Colombia 24
KE - Kenya 21
MA - Marocco 21
TW - Taiwan 19
LT - Lituania 17
PY - Paraguay 17
BE - Belgio 16
JO - Giordania 16
IR - Iran 15
PE - Perù 15
DZ - Algeria 14
JM - Giamaica 14
EG - Egitto 13
UZ - Uzbekistan 12
VE - Venezuela 12
SN - Senegal 11
TN - Tunisia 11
UY - Uruguay 11
GR - Grecia 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
AZ - Azerbaigian 9
DO - Repubblica Dominicana 9
NP - Nepal 9
CH - Svizzera 8
DK - Danimarca 8
SA - Arabia Saudita 8
HN - Honduras 7
IL - Israele 7
LB - Libano 7
MY - Malesia 7
BG - Bulgaria 6
CZ - Repubblica Ceca 5
EE - Estonia 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
CL - Cile 4
CR - Costa Rica 4
GT - Guatemala 4
HU - Ungheria 4
KZ - Kazakistan 4
LY - Libia 3
MD - Moldavia 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SI - Slovenia 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BF - Burkina Faso 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CY - Cipro 2
DM - Dominica 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
GF - Guiana Francese 2
HR - Croazia 2
HT - Haiti 2
KG - Kirghizistan 2
Totale 20.685
Città #
Singapore 1.534
San Jose 934
Ashburn 645
Moscow 584
Hong Kong 547
Santa Clara 455
Chandler 451
Ho Chi Minh City 401
Beijing 391
Amsterdam 307
Hanoi 295
Naples 237
Millbury 195
Los Angeles 192
Lauterbourg 186
Hefei 163
The Dalles 163
Munich 147
Tokyo 135
Boston 130
Princeton 111
Nanjing 104
Des Moines 103
New York 103
Napoli 93
Council Bluffs 90
Buffalo 86
Lappeenranta 84
São Paulo 80
Lawrence 74
Redondo Beach 71
Ottawa 68
Dallas 65
Da Nang 64
Frankfurt am Main 61
Wilmington 58
Turku 56
Haiphong 50
Milan 47
Jacksonville 46
Atlanta 44
Dong Ket 44
Orem 44
Chicago 43
Helsinki 43
Nuremberg 43
Woodbridge 43
Warsaw 37
Montreal 36
Rome 34
Brooklyn 33
Nanchang 33
Mexico City 32
Houston 31
Rio de Janeiro 30
Phoenix 29
Poplar 29
Seoul 29
Stockholm 29
Chennai 27
Tianjin 27
Hebei 26
London 26
Denver 25
Shenyang 25
Falkenstein 24
Washington 23
Toronto 22
Seattle 20
Bangkok 19
Redwood City 19
Biên Hòa 18
Hải Dương 18
Nairobi 17
San Francisco 17
Johannesburg 16
Boardman 15
Fairfield 15
Salerno 15
Sciacca 15
Amman 14
Baghdad 14
Jiaxing 14
Manchester 14
Belo Horizonte 13
Düsseldorf 13
Querétaro 13
Vienna 13
Brasília 12
Can Tho 12
New Delhi 12
Ninh Bình 12
Phủ Lý 12
Porto Alegre 12
Bologna 11
Dublin 11
Montevideo 11
Mumbai 11
Philadelphia 11
Quito 11
Totale 10.967
Nome #
Evidence-based directions for polypharmacy revision: The experience gained by the campania reference site in the framework of the eip-aha action group A1 and of the friendd pilot study 235
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 225
[Evaluation of therapeutical appropriateness in psychiatric treatment of schizophrenia, by integrating computer data records with clinical audit results] 220
PERSISTENZA IN TERAPIA NEI SOGGETTI IN TRATTAMENTO CON FARMACI PER L' OSTEOPOROSI 171
The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure 162
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App 157
Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania Region Database 154
Valutazione economica dello studio AVERT 153
Impact of Cost- Containment Policies on Biosimilars Market 151
Determinants of Non-Persistence to Antiosteoporotic Drugs by Using Administrative Database 150
Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-basad cohort study in Italy. 145
Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy 144
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice 144
IMPATTO DELLE POLITICHE DI COST-CONTAINMENT SUL MERCATO DEI BIOSIMILARI 144
ANALISI DEI PROFILI PRESCRITTIVI DEGLI ANTIPSICOTICI ATIPICI NELLA ASL CASERTA 143
Differences in drug use between men and women: An Italian cross sectional study 143
Cost Analysis of an Intensive Care Unit 141
La terapia farmacologica anti-osteoporotica: analisi della persistenza in Regione Campania. 140
Osteoporosis drugs in real-world clinical practice: an analysis of persistence 139
Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases 138
Consumption of biosimilar drugs in Campania Region in the years 2009 -2012 137
Antibiotic prescription in Southern Italian outpatients: Real-world data analysis of prevalence, socioeconomic and sociodemographic variables and geographic variability 136
How healthy is community-dwelling elderly population? Results from Southern Italy 135
Innovative Approaches to Active and Healthy Ageing: Campania Experience to Improve the Adoption of Innovative Good Practices 135
Gastroesophageal reflux disease (GERD) cost of care: Role of naive and relapsed symptoms in general practice 134
PPI general practitioners’prescribing in the treatment of acid-related disorders: the impact of generic PPI launch into the pharmaceutical market in Italy 133
Le politiche di compartecipazione alla spesa farmaceutica 132
Are you more concerned about or relieved by medicines? An explorative randomized study of the impact of telephone counseling by pharmacists on patients' beliefs regarding medicines and blood pressure control. 132
A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: Design and rationale of the EDU.RE.DRUG study 132
Drug-utilisation profiles and COVID-19 131
LA VALUTAZIONE DELLA COMUNICAZIONE MEDICO-PAZIENTE: LA ESPERIENZA DELLA A.O.R.N. A CARDARELLI 130
A Large-Scale Longitudinal Population-Based Study of Risk Reduction of Cardiovascular Complications in Patients on Bolus Insulin Analogues 130
Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA 130
Baseline drug treatments as indicators of increased risk of COVID-19 mortality in Spain and Italy 130
Predictors of non-persistence on statin treatments in Italy: a retrospective cohort study in primary care. 128
Cost Analysis of an intensive care unit 127
Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing 127
Postvaccination SARS-CoV-2 Infections among Healthcare Professionals: A Real World Evidence Study 126
Prevalence of antibiotic prescription in southern Italian outpatients: real-world data analysis of socioeconomic and sociodemographic variables at a municipality level 126
Proton pump inhibitors prescribing following the introduction of generic drugs 125
Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study. 125
Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy 125
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2) 124
Geolocation with respect to personal privacy for the Allergy Diary app - A MASK study 123
Assessment of surgeon communication skills from the patient perspective: A national evaluation using the Communication Assessment Tool 123
Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril/Valsartan among Patients with Heart Failure 122
Prescription Appropriateness of Drugs for Peptic Ulcer and Gastro-Esophageal Reflux Disease: Baseline Assessment in the LAPTOP-PPI Cluster Randomized Trial 122
Cost-Effectiveness of Treatment Optimisation with Biomarkers for Immunotherapy in Solid Tumours: A Systematic Review 122
Valutazione economica dello studio IDEAL 122
Influence of generic drugs on proton pump inhibitor prescription in primary care. 122
Proton pump inhibitors market in primary care setting. 122
Three-Year Health Care Expenditures in Diabetic Patients Receiving Rapid-Acting Insulin Analogues Versus Those on Human Regular Insulin 122
Influenza dei farmaci generici sulle dinamiche prescrittive degli inibitori di pompa protonica in medicina generale 121
Biological therapy utilization, switching, and cost among patients with psoriasis: Retrospective analysis of administrative databases in southern Italy 121
Assessment of Patterns of Initiation of Oral Anticoagulant Therapy in Hypertensive Patients with Atrial Fibrillation 121
Persistence as a robust indicator of medication adherence-related quality and performance 121
Imaging tests in staging and surveillance of early breast cancer in Italy. changes in routine clinical practice and costs implications 120
THE EFFECT OF A TELEPHONE COUNSELING INTERVENTION BY PHARMACIST ON PATIENTS' BELIEFS ABOUT MEDICINES AND BLOOD PRESSURE CONTROL 120
Prevalence of chronic obstructive pulmonary disease from administrative health services databases. 119
In real clinical practice osteoporosis drugs are taken for a very short period: analysis of persistence in the Campania region 119
Analysis of Prescribing Patterns of Atypical Antipsychotics in Lhu Caserta 118
Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: A retrospective observational study in Southern Italy 118
Gender-Related Behaviors in Drug Consumption In Italy 117
DIFFERENZE DI GENERE NELL???USO DEI FARMACI. ANALISI DEI DATI DI PRESCRIZIONE FARMACEUTICA IN ITALIA 117
The European Innovation Partnership on Active and Healthy Ageing Synergies: Protocol for a Prospective Observational Study to Measure the Impact of a Community-Based Program on Prevention and Mitigation of Frailty (ICP - PMF) in Community-Dwelling Older Adults 117
Cost analysis of anti-osteoporotic drugs in real-world clinical practice 117
GENDER DIFFERENCES IN MEDICATION TAKING BEHAVIOUR: A CASE OF OSTEOPOROSIS 117
THE USE OF REAL WORLD DATA TO BUILD ECONOMIC MODELS: A CASE STUDY OF OSTEOPOROSIS 117
Prevalence and Characterization of Potential PPI-Clopidogrel Interaction in a Prescription Database in 2006-2009 117
Drug Utilization Pattern of Antibiotics: The Role of Age, Sex and Municipalities in Determining Variation 117
THU0503 Cost analysis of anti-osteoporotic drugs in real-world clinical practice 116
Treatment patterns and medication adherence among newly diagnosed patients with migraine: a drug utilisation study 116
Inappropriate medication prescribing among elderly patients in Italy 114
La gestione della malattia acido correlata nella medicina di primo livello. Sinergie di utilizzo degli archivi informatizzati per l’informatizzati per l’informazione e la formazione e la formazione professione. 113
Persistence with antiosteoporotic drugs: a retrospective population-based color study. 113
Valutazione dell'impatto sulla spesa farmaceutica dell'organizzazione logistica 113
Persistence at one year with antiosteoporotic drugs in Southern Italy: analysis of administrative databases. 112
Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs 112
THU0504 Utilisation of anti-osteoporotic drugs in real-world data: a study of gender-related differences 112
THU0474 Utilisation of anti-osteoporotic drugs in real-world data: an analysis of persistence to therapy and risk of fracture 112
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study 112
Polypharmacy Management in Chronic Conditions: A Systematic Literature Review of Italian Interventions 111
AC4 - RETROSPECTIVE ANALYSIS OF INAPPROPRIATE MEDICATION PRESCRIPTION INDICATORS IN ELDERLY POPULATION IN ITALY 111
Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: A systematic review protocol 111
Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients 110
The value of the polypill in cardiovascular disease: an Italian multidisciplinary Delphi panel consensus 110
Changes in multimorbidity and polypharmacy patterns in young and adult population over a 4-year period: A 2011–2015 comparison using real-world data 110
Aspetti epidemiologici ed economici del diabete in Campania: analisi dei dati di prescrizione attraverso farmaci traccianti 109
PSY90 - RETROSPECTIVE ANALYSIS OF ADMINISTRATIVE DATA TO ASSESS ADHERENCE, PHARMACOUTILIZATION AND COSTS OF BIOLOGICAL THERAPY TREATMENT OF PSORIASIS IN SOUTHERN ITALIAN SETTING 109
Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1) 109
Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions-The EDU.RE.DRUG Project 108
Adaptation of communication assessment tool for community pharmacists in medication adherence and minor diseases management 108
Valutazione economica dello studio CARDS 107
Effectiveness of the CardioPain initiative in reducing inappropriate NSAID prescriptions in pain therapy among high cardiovascular risk patients: an informative Italian survey 107
Treatment Patterns And Drug-Related Costs For Patients with Psoriasis on Biologic Therapy: A Retrospective Cohort Study In Southern Italy 107
PIH31 - USE OF ADMINISTRATIVE DATA FOR ASSESSMENT OF MEDICATION PRESCRIPTION PRACTICE IN TWO ITALIAN SETTINGS 106
Pharmacoeconomic consequences of losartan therapy in patients undergoing Diabetes End-Stage Renal Disease. 105
PERSISTENCE TO THERAPY AND THE ASSOCIATED RISK OF FRACTURES WITH ANTIOSTEOPOROTIC DRUGS 105
2019 ARIA Care pathways for allergen immunotherapy 104
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence 103
Totale 12.718
Categoria #
all - tutte 67.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.013 8 3 11 1 9 44 4 28 135 84 239 447
2022/20231.301 195 79 41 61 127 135 3 98 173 283 77 29
2023/20241.089 36 154 183 82 64 100 19 112 17 68 191 63
2024/20255.592 267 270 19 58 236 384 571 364 370 571 2.003 479
2025/202610.482 1.155 667 994 1.081 1.832 486 1.161 696 1.255 690 255 210
2026/2027107 107 0 0 0 0 0 0 0 0 0 0 0
Totale 21.150